AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00908544 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PHI-patients
Description: Treatment initiation with multi drug class (MDC) HAART. 2 NRTI + 1 PI/r + Maraviroc + Raltegravir
Study NCT00908544 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CHI-patients
Description: Treatment intensification of PI-based HAART with Maraviroc and Raltegravir. 2 NRTI + 1 PI/r + Maraviroc + Raltegravir
Study NCT01541085 — intervention group
Intervention type: DRUG
Intervention: Darunavir/Ritonavir (DRV/r)
Description: Darunavir/Ritonavir (DRV/r) + Tenofovir/Emtricitabina regimen
Study NCT01541085 — intervention group
Intervention type: DRUG
Intervention: Efavirenz (EFV)
Description: Efavirenz (EFV) + Tenofovir/Emtricitabina regimen
Study NCT00618371 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raltegravir (MK-0518)
Description: Antiretroviral drug intensification with Raltegravir (MK0518) 400mg orally every 12 hours for 28 days in addition to the prescribed antiretroviral therapy
Study NCT01036854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EUR-1025
Description: orally, 24 mg, daily for 6 days
Study NCT01036854 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: EUR-1025
Description: orally, 8 mg, twice daily over 6 consecutive days
Study NCT01036854 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: EUR-1025
Description: orally, 8 mg, three times a day over 6 consecutive days
Study NCT01036854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EUR-1025
Description: orally, 8 mg, 16 mg, 24 mg, daily, for 6 days
Study NCT04159389 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mental visualization
Description: Instruction in mental visualization by theoretical lessons and support of practice by audio guide and session of experience sharing.
Study NCT01091194 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Interval-based aerobic exercise
Description: High intensity interval-based aerobic exercise training. Duration: 1 year. Three 8-weeks supervised periods of physical training 3 times per week. Individual training 2 times per week between these periods.
Study NCT04880486 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Education
Description: Usual pulmonary rehabilitation education and pharmacological therapies, and taught them some limbs exercise, using social application to contact and suggestion giving as supervision.
Study NCT04880486 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: Usual pulmonary rehabilitation education and pharmacological therapies, and taught them some limbs exercise, using social application to contact and suggestion giving as supervision.
Study NCT04880486 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supervision upper limb weight training exercise with VR
Description: Participant is supervised by physical therapist to conduct upper limb weight training exercise with VR.
Study NCT03596203 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TransCutaneous Magnetic Stimulator (TCMS)
Description: TCMS coils which are connected to feet and pulse generator. The generator will then be turned on to deliver 50 pulses at a pulse period of 6 seconds and at a pulse intensity of 100% to the bottom of the foot with the TCMS coil.
Study NCT00124748 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib mesylate
Description: Imatinib is packaged in bottles as 100mg and 400mg tablets
Study NCT05079048 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PEEK retentive elements
Description: received implant-supported mandibular overdenture retained by PEEK retentive element and housings
Study NCT05079048 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PEEK retentive elements
Description: received implant-supported mandibular overdenture retained by PEEK retentive element and housings
Study NCT04112303 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOF/VEL
Description: Tablets administered orally once daily
Study NCT03218436 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CAP treatment
Description: Treatment with low-temperature argon plasma during colposcopic examination. No general anesthesia required.
Study NCT03056742 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Stempeucel(R)
Description: Ex vivo cultured adult bone marrow derived allogeneic mesenchymal stem cells
Study NCT04637737 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: anterioposterior Weight Shifting Training with Visual Biofeedback
Description: The training group received an additional anterioposterior weight shifting training with visual Biofeedback 5 times per week for 4weeks. AP training is made to instantly know your training status during training by measuring and processing the foot pressure in real time using the F-Scan (Tekscan) hardware system and Software Development Kit (SDK).~Before training, all patients are instructed to place both feet at shoulder width, place the inverted foot approximately 30 cm in front of the unaffected side foot, move the body forward with the chest straight in an upright position, and be instructed to put the weight on the affected side.~On the screen shown, measure the maximum weight distribution during the first 10 times and set the value added by 5% as the target value.~It is designed to induce the maximum weight shift through the archery game.
Study NCT04637737 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Conventional therapy
Description: The control group received the usual gait training.
Study NCT00612755 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginterferon alfa-2a + ribavirin
Description: Peginterferon alfa-2a 180 mcg/week ribavirin 1000-1200 mg/day during 24 weeks
Study NCT04851054 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery for colon cancer with intention to cure
Description: Surgery by open or laparoscopic approach
Study NCT00740584 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3% SPL7013 Gel (VivaGel)
Description: A single application of VivaGel applied to the vagina on five separate occasions, each occasion separated by a minimum of 5 days.
Study NCT02682368 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Point of Care Ultrasound by Surgeons (POCUSS)
Description: POCUSS-1. To identify the gallbladder and it's contents, complications and perform measurements, elicit sonographic Murphy.~POCUSS-2: To perform focused left lower quadrant sonography and identify bowel wall thickness, diverticulae, measure the colonic wall thickness, assess pericolic fat and detect possible complications; evaluate sensibility on graded compression.
Study NCT02682368 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Radiology report
Description: Radiologist report compared to the point of care ultrasound impression.
Study NCT02682368 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery-Intra-operative findings
Description: Intra-operative findings compared to the previously performed point of care ultrasound.
Study NCT01818596 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E/C/F/TAF
Description: E/C/F/TAF (150/150/200/10 mg) FDC tablet administered orally once daily with food
Study NCT04402879 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prone Positioning (PP)
Description: The intervention for this study is PP. Patients at participating sites allocated to the intervention arm of the study will be prompted by ward nurses and respiratory therapists to assume and maintain a prone position for varying durations, four times per day until the occurrence of a primary outcome event or hospital discharge.~The target duration (dose) of PP is > 8 hours per day for up to 60 days, or until oxygen requirements are \< 2 L per minute or \< 2 L per minute above baseline home oxygen requirements.
Study NCT01366482 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cotavance Drug-Eluting Balloon
Description: Treatment with a paclitaxel-coated angioplasty balloon (without preceding plaque excision)
Study NCT01366482 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TurboHawk/SilverHawk + Cotavance Drug-Eluting Balloon
Description: Plaque excision with a SilverHawk or TurboHawk plaque excision device followed by treatment with a paclitaxel-coated angioplasty balloon
Study NCT01366482 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TurboHawk/SilverHawk + Cotavance Drug-Eluting Balloon
Description: Plaque excision followed by treatment with a paclitaxel-coated angioplasty balloon
Study NCT04392843 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Fasting
Description: Subjects remain fasted prior to insulin-induced hypoglycemia.
Study NCT04392843 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Feeding
Description: Subjects eat a normal breakfast and lunch prior to insulin-induced hypoglycemia.
Study NCT03801174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Partner-assisted intervention
Description: All patients will receive group-based weight loss program for 6 months featuring a calorie-restricted diet and physical activity. Then, all patients will receive a weight loss maintenance intervention for 12 months that involves maintenance-specific content, transitions to individual telephone calls, and decreases frequency of contact. Partners will attend some patient group sessions and be informed of patients' goals and relapse plans. Intervention will be withdrawn for the last 6 months to examine sustainability of effects.
Study NCT03801174 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient-only intervention
Description: All patients will receive group-based weight loss program for 6 months featuring a calorie-restricted diet and physical activity. Then, all patients will receive a weight loss maintenance intervention for 12 months that involves maintenance-specific content, transitions to individual telephone calls, and decreases frequency of contact. Intervention will be withdrawn for the last 6 months to examine sustainability of effects.
Study NCT03162822 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral Intervention
Description: The behavioral intervention has the parents develop an if-then plan for dealing with conflict and negativity, using strategies to downregulate their own negative emotions.
Study NCT03162822 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Intervention
Description: The cognitive intervention has parents come up with reasons why their children do things they don't like, until they come up with benign attributions for those behaviors.
Study NCT03162822 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interpretation Bias Intervention
Description: The Interpretation Bias intervention has parents look at morphed facial expressions and determine whether the face is happy or angry. Positive feedback is given for rating the faces as happy and negative feedback is given for rating the faces as angry.
Study NCT03162822 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Evaluative Conditioning
Description: The Evaluative Conditioning intervention presents parents with pictures of ambiguous child faces (conditioned stimuli) and pairs them with positive word descriptors (unconditioned stimuli; e.g., sweet; cooperative).
Study NCT01086774 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systane Ultra Lubricant Eye Drops
Description: Single drop in both eyes
Study NCT02742220 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isometric Handgrip Training Group
Description: Intervention period will last eight weeks. Experimental group will perform three sessions per week of home-based handgrip exercise. The exercise protocol will consist of four unilateral sets (dominant arm) with two minutes of isometric contraction, with 30% of maximum voluntary contraction, and four minutes of interval between sets. Patients will receive a diary to record the sessions and report difficulties during the training. Visits will be scheduled at weeks 1 and 5 to provide feedback to individuals, discuss possible problems during the training and adjust the intensity of the exercise. In addition the patients be recommended to increase daily physical activity levels, and weekly, there will be phone contacts with the patients to reinforce the exercise recommendations.
Study NCT02742220 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control Group
Description: Intervention period will last eight weeks. Patients will be recommended to increase daily physical activity levels, and weekly, there will be phone contacts to reinforce the recommendations.
Study NCT04199429 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relationship-Based Care
Study NCT01008059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alfentanil
Description: No drug treatment before alfentanil
Study NCT04199429 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relationship-Based Care
Study NCT01715506 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational intervention
Description: The educational intervention (EI), Relation Related Care (RRC), consists of a two-day seminar and one hour monthly guidance for six months. Course material, a book particularly designed for this intervention and dealing with person centered care and use of restraint, is distributed ahead of the course part of the intervention to all participants.
Study NCT02090452 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Real time transmission of patient related data. Device used: MobiMed 3.1, manufactured by Ortivus AB Sweden
Study NCT00270400 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nesiritide
Study NCT01362231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-6624
Description: Patients will be treated with GS-6624 (125 or 200 mg) administered IV over 1 hour on specific days during the treatment period.
Study NCT04198974 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PreVenture Training (PTtT)
Description: PreVenture TtT model will involve identifying local expert trainers to be trained to train school-based professionals on the PreVenture program. Steps include:~1. PreVenture Facilitator certification: Trainers participate in training workshops and deliver the program to eligible youth in Cohort 1 and are rated on quality of implementation using the PIFA.~2. Reliable use of the PIFA: Each trainer demonstrates convergence with the Montreal Team's ratings on a set of previously-recorded PreVenture sessions.~3. PreVenture Training Workshop Certification: Trainers participate in a one-day TtT workshop to review the main aims and exercises of PreVenture Training. Trainers then record mock TtT sessions in which key components of the PreVenture Training Workshop are delivered to an audience of 4-10 individuals (e.g., class of graduate students). These sessions are rated by the Montreal Team the PreVenture Implementation Fidelity and Adherence-Trainer Scale (PIFA-T).
Study NCT04198974 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PreVenture Training+Implementation Facilitation
Description: PreVenture TtT model + Implementation Facilitation Package:~1. Youth advisors identified the role of older youth to support program implementation. Youth will help promote PreVenture to students and families and help Facilitators optimize attendance at sessions.~2. Trainer-led coaching sessions will focus on enhancing program fidelity and acceptability by Facilitators. 'Best practice' supervision elements from efficacy trials will be integrated. Fidelity and symptom monitoring will be conducted in real-time during program implementation.~3. Performance metrics have been developed based on youth qualitative feedback to PreVenture sessions in previous trials. Analysis indicates key responses that are predictive of students most likely to benefit from PreVenture on 12-month substance use outcomes and indicates the extent to which Facilitator's interventions are leaving students with impressions consistent with positive long-term outcomes.
Study NCT01619709 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Pet AV-45
Description: AV-45 (Florbetapir F 18) : Bolus of 5 MBq/kg IV ; A 10-minutes Pet scan acquisition Starts at 50 minutes after injection.
Study NCT03267199 — intervention group
Intervention type: DRUG
Intervention: Thrombolytic
Description: Thrombolytic therapy
Study NCT03267199 — intervention group
Intervention type: PROCEDURE
Intervention: Primary PCI
Description: Primary percutaneous coronary intervention
Study NCT03852316 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Click Device
Description: A single-use device containing a polymerase chain reaction (PCR)-based nucleic acid amplification test (NAAT) for detection of deoxyribonucleic acid (DNA) from Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) in self-collected vaginal specimens.
Study NCT03050905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VEKIRAX
Description: Patients will be treated according to label recommendation as for GT1b (with and without cirrhosis) for 12 weeks. All subjects will receive Ombitasvir+Paritaprevir+Ritonavir (Viekirax).~Study Regimen: ombitasvir+paritaprevir+ritonavir (25+150+100mg once daily)
Study NCT03050905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EXVIERA
Description: Patients will be treated according to label recommendation as for GT1b (with and without cirrhosis) for 12 weeks. All subjects will receive Dasabuvir (Exviera).~Study Regimen: dasabuvir (250 mg twice daily)
Study NCT03267199 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Complete blood count
Description: Blood sample for complete blood count
Study NCT03267199 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Platelet function test
Description: Blood sample for platelet function test
Study NCT03267199 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ECG
Description: Electrocardiogram
Study NCT02991911 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MEDI3726 Post-Chemo
Description: Single agent MEDI3726 after abiraterone or enzalutatmide, with a prior taxane-based chemotherapy in the mCRPC setting
Study NCT02991911 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MEDI3726 Pre-Chemo
Description: Single agent MEDI3726 after abiraterone or enzalutatmide, without a prior taxane-based chemotherapy in the mCRPC setting
Study NCT02991911 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MEDI3726 & Enzalutamide Combo
Description: MEDI3726 in combination with Enzalutatmide after prior treatment with abiraterone, with or without a prior taxane-based chemotherapy in the mCRPC setting
Study NCT02279602 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fosbretabulin
Description: fosbretabullin, 60 mg/m2 weekly for up to 1 year
Study NCT00588120 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C-13 labeled oxalate
Description: A single prescribed dose of C-13 labeled oxalate will be given orally in capsule form or in jello. Urine will be collected for 24 hours after the dose.~Take one capsule by mouth for one day.
Study NCT04218058 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: reduction of zygomatic arch in zygomaticomaxillary complex fracture
Description: ultrasound guided reduction of zygomatic arch
Study NCT01091792 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab every 2 weeks 10mg/kg beginning 2 weeks after start of Radiation Therapy
Study NCT03081585 — intervention group
Intervention type: BEHAVIORAL
Intervention: Satiety State
Description: Participants were scanned twice: once after a meal and once after fasting for 24 hours
Study NCT01161329 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Exercise Programmes (HIFE)
Description: Hife include functional exercises consisting of everyday tasks challenging leg strength, postural stability, and gait ability. All exercise shall be performed in weight-bearing positions, eg squats and walking over obstacles. HIFE are performed twice a week during 1 h. for three months in a group with 6-7 seven patients with stroke. Two physiotherapists lead the group and one physiotherapist select exercises for each participant according to their functional deficits. The exercises will be progressively increased in load and difficulty.
Study NCT00810953 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pentamidine
Description: two dose of 6 mg/kg with or without standard chemotherapy.
Study NCT04173143 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Craniocervical flexion training with pressure biofeedback
Description: Total 15 patients participated in this training group. Session was performed thrice in a week. Each session was givenfor approximately 20minutesPatients were asked to lie in supine hook lying position. After that Pressure biofeedback unit's air bag was clipped together and folded in three and positioned behind the neck just below the occiput. Patients were advised to perform Craniocervical flexion and practiced head nodding action to progressively target (reach the incremental targets) and hold the 5 pressure levels for 10 second between 22 mm Hg and 30 mmHg. A 2 minute second rest period was provided between each level. Minimum performance requirement was 26 mm Hg while ideal performance targets are 28 and 30 mm Hg... Patient will be re-assessed for all baseline variables after 4 weeks of training